Naveen Manisundaram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Naveen Manisundaram has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- George J. Chang
Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
5 shared publications Abhineet Uppal
Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
3 shared publicationsSandra R. DiBrito
Department of Surgery, Albany Medical Center, Albany, USA
3 shared publicationsChung-Yuan Hu
Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
2 shared publicationsJoshua N. Herb
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
2 shared publicationsNir Stanietzky
Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
2 shared publications
Latest Publications
- 16 July 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 248, 116523
Exploring the role of quality of life in surgical decision making for patients undergoing pancreatectomy
- 16 July 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 248, 116523
Exploring the role of quality of life in surgical decision making for patients undergoing pancreatectomy
- 31 May 2025
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-10
Disparities in Survival Across Multiple Cancer Sites at Low-Income-Serving Hospitals
Social determinants of health play a significant role in the incidence, diagnosis, and treatment of cancers, contributing to healthcare disparities. Howeve
- 31 May 2025
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-10
Disparities in Survival Across Multiple Cancer Sites at Low-Income-Serving Hospitals
Social determinants of health play a significant role in the incidence, diagnosis, and treatment of cancers, contributing to healthcare disparities. Howeve
Impact of Medicaid expansion on racial disparities among patients with gastrointestinal cancer
Background: Racial minority groups experience disparities in cancer treatment and mortality. This study aimed to investigate the effect of Medicaid expansion on the existing racial disparities in all‐cause mortality among patients with gastrointestinal malignancies.Methods: A cross‐sectional cohort study of patients with pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), and gastric adenocarcinoma (GC) of any stage was conducted using data from the National Cancer Database (2009–2019). Using difference‐in‐difference (DID) analysis, the authors compared adjusted 2‐year mortality rates among Black and White patients residing in states with expanded Medicaid benefits (MES) and non‐MES before (2009–2013) and after (2014–2019) Medicaid expansion.Results: A total of 86,052 patients were included in this analysis, including 19,188 patients with PDAC, 60,404 with CRC, and 6460 with GC. Two‐year mortality rates decreased among Black patients with PDAC residing in MES but not those residing in non‐MES following Medicaid expansion (DID, –9.4%; 95% confidence interval [CI], –14.4% to –4.4%; p < .001). Mortality decreased more among Black and White patients with CRC in MES compared to those in non‐MES following Medicaid expansion (DID, –2.9%; 95% CI, –5.7 to –0.04; p = .047 and DID, –4.2%; 95% CI, –5.8 to –2.5; p < .001, respectively). Black patients with GC in MES experienced a marked reduction in mortality compared to those in non‐MES (DID, –7.7%, 95% CI, –16.1 to 0.56; p = .07).Conclusion: Medicaid expansion was associated with a greater reduction in 2‐year mortality rates among Black patients residing in MES compared to those residing in non‐MES. Existing racial disparities in mortality remained the same or worsened in non‐MES but were mitigated in MES following Medicaid expansion in almost all comparisons.
Impact of Medicaid expansion on racial disparities among patients with gastrointestinal cancer
Background: Racial minority groups experience disparities in cancer treatment and mortality. This study aimed to investigate the effect of Medicaid expansion on the existing racial disparities in all‐cause mortality among patients with gastrointestinal malignancies.Methods: A cross‐sectional cohort study of patients with pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), and gastric adenocarcinoma (GC) of any stage was conducted using data from the National Cancer Database (2009–2019). Using difference‐in‐difference (DID) analysis, the authors compared adjusted 2‐year mortality rates among Black and White patients residing in states with expanded Medicaid benefits (MES) and non‐MES before (2009–2013) and after (2014–2019) Medicaid expansion.Results: A total of 86,052 patients were included in this analysis, including 19,188 patients with PDAC, 60,404 with CRC, and 6460 with GC. Two‐year mortality rates decreased among Black patients with PDAC residing in MES but not those residing in non‐MES following Medicaid expansion (DID, –9.4%; 95% confidence interval [CI], –14.4% to –4.4%; p < .001). Mortality decreased more among Black and White patients with CRC in MES compared to those in non‐MES following Medicaid expansion (DID, –2.9%; 95% CI, –5.7 to –0.04; p = .047 and DID, –4.2%; 95% CI, –5.8 to –2.5; p < .001, respectively). Black patients with GC in MES experienced a marked reduction in mortality compared to those in non‐MES (DID, –7.7%, 95% CI, –16.1 to 0.56; p = .07).Conclusion: Medicaid expansion was associated with a greater reduction in 2‐year mortality rates among Black patients residing in MES compared to those residing in non‐MES. Existing racial disparities in mortality remained the same or worsened in non‐MES but were mitigated in MES following Medicaid expansion in almost all comparisons.
- Top Cited Papers
- 2 January 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (4) , 426-436
Rise in Minimally Invasive Surgery for Colorectal Cancer Is Associated With Adoption of Robotic Surgery
BACKGROUND: Minimally invasive surgery is associated with improved short-term outcomes and similar long-term oncologic outcomes for patients with colorectal cancer compared with open surgery. Although the robotic approach has ergonomic and technical benefits, how it has impacted the utilization of traditional laparoscopic surgery and minimally invasive surgery overall is unclear. OBJECTIVE: Describe trends in open, robotic, and laparoscopic approaches for colorectal cancer resections and examine factors associated with minimally invasive surgery. DESIGN: Retrospective cohort study using data from the National Cancer Database from 2010 to 2020. SETTING: Commission on Cancer–accredited US facilities. PATIENTS: Patients diagnosed with nonmetastatic colon or rectal adenocarcinoma. MAIN OUTCOME MEASURES: Surgical approach rates (open, robotic, and laparoscopic). RESULTS: We identified 475,001 patients diagnosed with nonmetastatic colorectal adenocarcinoma, of whom 192,237 (40.5%) underwent open surgery, 64,945 (13.7%) underwent robotic surgery, and 217,819 (45.9%) underwent laparoscopic surgery. For colon cancer, laparoscopic minimally invasive surgery use steadily increased, with a peak prevalence of 54.0% in 2016, and total minimally invasive surgery (robotic + laparoscopic) was performed more often than open surgery from 2013 through 2020. For rectal cancer, laparoscopic minimally invasive surgery had a peak prevalence of 37.2% in 2014 and declined from 2014 through 2020; robotic surgery prevalence increased throughout the study period (5.5% in 2010, 24.7% in 2015, and 48.8% in 2020). Minimally invasive surgery use increased in facilities performing robotic surgery every year during the study period. For both colon and rectal cancer, the use of open surgery decreased across all facilities throughout the study period. LIMITATIONS: This study used the National Cancer Database, which may not be generalizable to non–Commission on Cancer institutions. CONCLUSIONS: Minimally invasive surgery steadily increased across all facilities from 2010 through 2020. Open resections declined, laparoscopic resections plateaued, and robotic resections increased for colon and rectal cancer. Minimally invasive surgery increases may be driven by increases in robot-assisted surgery. See Video Abstract. EL AUMENTO DE LA CIRUGÍA MÍNIMAMENTE INVASIVA PARA EL CÁNCER COLORRECTAL SE ASOCIA CON LA ADOPCIÓN A LA CIRUGÍA ROBÓTICA: ANTECEDENTES: La cirugía mínimamente invasiva se asocia con mejores resultados a corto plazo y resultados oncológicos similares a largo plazo para pacientes con cáncer colorrectal en comparación con la cirugía abierta. Aunque el abordaje robótico tiene beneficios ergonómicos y técnicos, no está claro cómo ha afectado la utilización de la cirugía laparoscópica tradicional y la cirugía mínimamente invasiva en general. OBJETIVO: Describir las tendencias en los abordajes abiertos, robóticos y laparoscópicos para las resecciones de cáncer colorrectal y examinar los factores asociados con la cirugía mínimamente invasiva. DISEÑO: Estudio de cohorte retrospectivo utilizando datos de la Base de Datos Nacional del Cáncer desde 2010 hasta 2020. ESCENARIO: Centros estadounidenses acreditados por la Comisión sobre el Cáncer. PACIENTES: Pacientes diagnosticados con adenocarcinoma de colon o recto no metastásico. PRINCIPALES MEDIDAS DE VALORACIÓN: Tasas de abordaje quirúrgico (abierto, robótico, laparoscópico). RESULTADOS: Identificamos 475.001 pacientes con diagnóstico de adenocarcinoma colorrectal no metastásico, de los cuales 192.237 (40,5%) se sometieron a cirugía abierta, 64.945 (13,7%) se sometieron a cirugía robótica y 217.819 (45,9%) se sometieron a cirugía laparoscópica. Para el cáncer de colon, el uso de cirugía mínimamente invasiva laparoscópica aumentó de manera constante, con una prevalencia máxima del 54,0% en 2016, y la cirugía mínimamente invasiva total (robótica + laparoscópica) se realizó con mayor frecuencia que la cirugía abierta desde 2013 hasta 2020. Para el cáncer de recto, la cirugía mínimamente invasiva laparoscópica tuvo una prevalencia máxima del 37,2% en 2014 y disminuyó desde 2014 hasta 2020; La prevalencia de la cirugía robótica aumentó durante el período de estudio (5,5 % en 2010, 24,7 % en 2015, 48,8 % en 2020). El uso de cirugía mínimamente invasiva aumentó en los centros que realizan cirugía robótica cada año durante el período de estudio. Tanto para el cáncer de colon como para el cáncer de recto, el uso de cirugía abierta disminuyó en todos los centros durante el período de estudio. LIMITACIONES: Se utilizó la base de datos nacional sobre el cáncer, que puede no ser generalizable a instituciones que no pertenecen a la Comisión sobre el Cáncer. CONCLUSIONES: La cirugía mínimamente invasiva aumentó de manera constante en todos los centros entre 2010 y 2020. Las resecciones abiertas disminuyeron, las resecciones laparoscópicas se estabilizaron y las resecciones robóticas aumentaron para el cáncer de colon y recto. Los aumentos de la cirugía mínimamente invasiva pueden estar impulsados por aumentos en la cirugía asistida por robot. (Traducción--Ingrid Melo)
- 2 January 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (4) , 426-436
Top Cited PapersRise in Minimally Invasive Surgery for Colorectal Cancer Is Associated With Adoption of Robotic Surgery
BACKGROUND: Minimally invasive surgery is associated with improved short-term outcomes and similar long-term oncologic outcomes for patients with colorectal cancer compared with open surgery. Although the robotic approach has ergonomic and technical benefits, how it has impacted the utilization of traditional laparoscopic surgery and minimally invasive surgery overall is unclear. OBJECTIVE: Describe trends in open, robotic, and laparoscopic approaches for colorectal cancer resections and examine factors associated with minimally invasive surgery. DESIGN: Retrospective cohort study using data from the National Cancer Database from 2010 to 2020. SETTING: Commission on Cancer–accredited US facilities. PATIENTS: Patients diagnosed with nonmetastatic colon or rectal adenocarcinoma. MAIN OUTCOME MEASURES: Surgical approach rates (open, robotic, and laparoscopic). RESULTS: We identified 475,001 patients diagnosed with nonmetastatic colorectal adenocarcinoma, of whom 192,237 (40.5%) underwent open surgery, 64,945 (13.7%) underwent robotic surgery, and 217,819 (45.9%) underwent laparoscopic surgery. For colon cancer, laparoscopic minimally invasive surgery use steadily increased, with a peak prevalence of 54.0% in 2016, and total minimally invasive surgery (robotic + laparoscopic) was performed more often than open surgery from 2013 through 2020. For rectal cancer, laparoscopic minimally invasive surgery had a peak prevalence of 37.2% in 2014 and declined from 2014 through 2020; robotic surgery prevalence increased throughout the study period (5.5% in 2010, 24.7% in 2015, and 48.8% in 2020). Minimally invasive surgery use increased in facilities performing robotic surgery every year during the study period. For both colon and rectal cancer, the use of open surgery decreased across all facilities throughout the study period. LIMITATIONS: This study used the National Cancer Database, which may not be generalizable to non–Commission on Cancer institutions. CONCLUSIONS: Minimally invasive surgery steadily increased across all facilities from 2010 through 2020. Open resections declined, laparoscopic resections plateaued, and robotic resections increased for colon and rectal cancer. Minimally invasive surgery increases may be driven by increases in robot-assisted surgery. See Video Abstract. EL AUMENTO DE LA CIRUGÍA MÍNIMAMENTE INVASIVA PARA EL CÁNCER COLORRECTAL SE ASOCIA CON LA ADOPCIÓN A LA CIRUGÍA ROBÓTICA: ANTECEDENTES: La cirugía mínimamente invasiva se asocia con mejores resultados a corto plazo y resultados oncológicos similares a largo plazo para pacientes con cáncer colorrectal en comparación con la cirugía abierta. Aunque el abordaje robótico tiene beneficios ergonómicos y técnicos, no está claro cómo ha afectado la utilización de la cirugía laparoscópica tradicional y la cirugía mínimamente invasiva en general. OBJETIVO: Describir las tendencias en los abordajes abiertos, robóticos y laparoscópicos para las resecciones de cáncer colorrectal y examinar los factores asociados con la cirugía mínimamente invasiva. DISEÑO: Estudio de cohorte retrospectivo utilizando datos de la Base de Datos Nacional del Cáncer desde 2010 hasta 2020. ESCENARIO: Centros estadounidenses acreditados por la Comisión sobre el Cáncer. PACIENTES: Pacientes diagnosticados con adenocarcinoma de colon o recto no metastásico. PRINCIPALES MEDIDAS DE VALORACIÓN: Tasas de abordaje quirúrgico (abierto, robótico, laparoscópico). RESULTADOS: Identificamos 475.001 pacientes con diagnóstico de adenocarcinoma colorrectal no metastásico, de los cuales 192.237 (40,5%) se sometieron a cirugía abierta, 64.945 (13,7%) se sometieron a cirugía robótica y 217.819 (45,9%) se sometieron a cirugía laparoscópica. Para el cáncer de colon, el uso de cirugía mínimamente invasiva laparoscópica aumentó de manera constante, con una prevalencia máxima del 54,0% en 2016, y la cirugía mínimamente invasiva total (robótica + laparoscópica) se realizó con mayor frecuencia que la cirugía abierta desde 2013 hasta 2020. Para el cáncer de recto, la cirugía mínimamente invasiva laparoscópica tuvo una prevalencia máxima del 37,2% en 2014 y disminuyó desde 2014 hasta 2020; La prevalencia de la cirugía robótica aumentó durante el período de estudio (5,5 % en 2010, 24,7 % en 2015, 48,8 % en 2020). El uso de cirugía mínimamente invasiva aumentó en los centros que realizan cirugía robótica cada año durante el período de estudio. Tanto para el cáncer de colon como para el cáncer de recto, el uso de cirugía abierta disminuyó en todos los centros durante el período de estudio. LIMITACIONES: Se utilizó la base de datos nacional sobre el cáncer, que puede no ser generalizable a instituciones que no pertenecen a la Comisión sobre el Cáncer. CONCLUSIONES: La cirugía mínimamente invasiva aumentó de manera constante en todos los centros entre 2010 y 2020. Las resecciones abiertas disminuyeron, las resecciones laparoscópicas se estabilizaron y las resecciones robóticas aumentaron para el cáncer de colon y recto. Los aumentos de la cirugía mínimamente invasiva pueden estar impulsados por aumentos en la cirugía asistida por robot. (Traducción--Ingrid Melo)
- 3 July 2024
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 67 (10) , 1281-1290
The Learning Curve for Robotic Lateral Pelvic Lymph Node Dissection for Rectal Cancer: A View From the West
BACKGROUND: Lateral pelvic lymph node dissection is performed for selected patients with rectal cancer with persistent lateral nodal disease after neoadjuvant therapy. This technique has been slow to be adopted in the West because of concerns regarding technical difficulty. This is the first report on the learning curve for lateral pelvic lymph node dissection in the United States or Europe. OBJECTIVE: This study aimed to analyze the learning curve associated with robotic lateral pelvic lymph node dissection. DESIGN: Retrospective observational cohort. SETTING: Tertiary academic cancer center. PATIENTS: Consecutive patients from 2012 to 2021. INTERVENTION: All patients underwent robotic lateral pelvic lymph node dissection. MAIN OUTCOME MEASURES: The primary end points were the learning curves for the maximum number of nodes retrieved and urinary retention, which was evaluated with simple cumulative sum and 2-sided Bernoulli cumulative sum charts. RESULTS: Fifty-four procedures were included. A single-surgeon learning curve (n = 35) and an institutional learning curve are presented in the analysis. In the single-surgeon learning curve, a turning point marking the end of a learning phase was detected at the 12th procedure for the number of retrieved nodes and at the 20th procedure for urinary retention. In the institutional learning curve analysis, 2 turning points were identified at the 13th procedure, indicating progressive improvements for the number of retrieved nodes, and at the 27th procedure for urinary retention. No sustained alarm signals were detected at any time point. LIMITATIONS: The retrospective nature, small sample size, and the referral center nature of the reporting institution may limit generalizability. CONCLUSIONS: In a setting of institutional experience with robotic colorectal surgery, including beyond total mesorectal excision resections, the learning curve for robotic lateral pelvic lymph node dissection is acceptably short. Our results demonstrate the feasibility of the acquisition of this technique in a controlled setting, with sufficient case volume and proctoring to optimize the learning curve. See Video Abstract. LA CURVA DE APRENDIZAJE DE LA DISECCIÓN ROBÓTICA DE LOS GANGLIOS LINFÁTICOS PÉLVICOS LATERALES EN EL CÁNCER DE RECTO: UNA VISIÓN DESDE OCCIDENTE: ANTECEDENTES: La disección lateral de los ganglios linfáticos pélvicos se realiza en pacientes seleccionados con cáncer de recto con enfermedad ganglionar lateral persistente tras el tratamiento neoadyuvante. La adopción de esta técnica en Occidente ha sido lenta debido a la preocupación por su dificultad técnica. Éste es el primer informe sobre la curva de aprendizaje de la disección de los ganglios linfáticos pélvicos laterales en EE.UU. o Europa. OBJETIVO: El objetivo de este estudio fue analizar la curva de aprendizaje asociada a la disección robótica de los ganglios linfáticos pélvicos laterales. DISEÑO: Cohorte observacional retrospectiva. LUGAR: Centro oncológico académico terciario. PACIENTES: Pacientes consecutivos desde 2012 al 2021. INTERVENCIÓN: Todos los pacientes fueron sometieron a disección robótica de ganglios linfáticos pélvicos laterales. PRINCIPALES MEDIDAS DE RESULTADO: Los criterios de valoración primarios fueron las curvas de aprendizaje tomando en cuenta el mayor número de ganglios recuperados y la retención urinaria que fueron evaluados con gráficos de suma acumulativa simple y de suma acumulativa de Bernoulli de dos caras. RESULTADOS: Fueron incluidos 54 procedimientos. En el análisis se presentan una curva de aprendizaje de un solo cirujano (n = 35) y una curva de aprendizaje institucional. En la curva de aprendizaje de un solo cirujano, se detectó un punto de inflexión que marcaba el final de una fase de aprendizaje en el duodécimo procedimiento para el número de ganglios extraídos y en el vigésimo para la retención urinaria. En el análisis de la curva de aprendizaje institucional, se identificaron dos puntos de inflexión en las intervenciones 13.ª y 26.ª, que indicaron mejoras progresivas en el número de ganglios extraídos, y en la 27.ª en la retención urinaria. No se detectaron señales de alarma sostenidas en ningún momento. LIMITACIONES: La naturaleza retrospectiva, el pequeño tamaño de la muestra y la naturaleza de centro de referencia de la institución informante que pueden limitar la capacidad de generalizarse. CONCLUSIONES: En un entorno de experiencia institucional con cirugía robótica colorrectal incluyendo más allá de las resecciones TME, la curva de aprendizaje para la disección robótica de ganglios linfáticos pélvicos laterales es aceptablemente corta. Nuestros resultados demuestran la viabilidad de la adquisición de esta técnica en un entorno controlado, con un volumen de casos suficiente y una supervisión que puede optimizar la curva de aprendizaje. (Traducción—Dr. Osvaldo Gauto)
- 3 July 2024
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 67 (10) , 1281-1290
The Learning Curve for Robotic Lateral Pelvic Lymph Node Dissection for Rectal Cancer: A View From the West
BACKGROUND: Lateral pelvic lymph node dissection is performed for selected patients with rectal cancer with persistent lateral nodal disease after neoadjuvant therapy. This technique has been slow to be adopted in the West because of concerns regarding technical difficulty. This is the first report on the learning curve for lateral pelvic lymph node dissection in the United States or Europe. OBJECTIVE: This study aimed to analyze the learning curve associated with robotic lateral pelvic lymph node dissection. DESIGN: Retrospective observational cohort. SETTING: Tertiary academic cancer center. PATIENTS: Consecutive patients from 2012 to 2021. INTERVENTION: All patients underwent robotic lateral pelvic lymph node dissection. MAIN OUTCOME MEASURES: The primary end points were the learning curves for the maximum number of nodes retrieved and urinary retention, which was evaluated with simple cumulative sum and 2-sided Bernoulli cumulative sum charts. RESULTS: Fifty-four procedures were included. A single-surgeon learning curve (n = 35) and an institutional learning curve are presented in the analysis. In the single-surgeon learning curve, a turning point marking the end of a learning phase was detected at the 12th procedure for the number of retrieved nodes and at the 20th procedure for urinary retention. In the institutional learning curve analysis, 2 turning points were identified at the 13th procedure, indicating progressive improvements for the number of retrieved nodes, and at the 27th procedure for urinary retention. No sustained alarm signals were detected at any time point. LIMITATIONS: The retrospective nature, small sample size, and the referral center nature of the reporting institution may limit generalizability. CONCLUSIONS: In a setting of institutional experience with robotic colorectal surgery, including beyond total mesorectal excision resections, the learning curve for robotic lateral pelvic lymph node dissection is acceptably short. Our results demonstrate the feasibility of the acquisition of this technique in a controlled setting, with sufficient case volume and proctoring to optimize the learning curve. See Video Abstract. LA CURVA DE APRENDIZAJE DE LA DISECCIÓN ROBÓTICA DE LOS GANGLIOS LINFÁTICOS PÉLVICOS LATERALES EN EL CÁNCER DE RECTO: UNA VISIÓN DESDE OCCIDENTE: ANTECEDENTES: La disección lateral de los ganglios linfáticos pélvicos se realiza en pacientes seleccionados con cáncer de recto con enfermedad ganglionar lateral persistente tras el tratamiento neoadyuvante. La adopción de esta técnica en Occidente ha sido lenta debido a la preocupación por su dificultad técnica. Éste es el primer informe sobre la curva de aprendizaje de la disección de los ganglios linfáticos pélvicos laterales en EE.UU. o Europa. OBJETIVO: El objetivo de este estudio fue analizar la curva de aprendizaje asociada a la disección robótica de los ganglios linfáticos pélvicos laterales. DISEÑO: Cohorte observacional retrospectiva. LUGAR: Centro oncológico académico terciario. PACIENTES: Pacientes consecutivos desde 2012 al 2021. INTERVENCIÓN: Todos los pacientes fueron sometieron a disección robótica de ganglios linfáticos pélvicos laterales. PRINCIPALES MEDIDAS DE RESULTADO: Los criterios de valoración primarios fueron las curvas de aprendizaje tomando en cuenta el mayor número de ganglios recuperados y la retención urinaria que fueron evaluados con gráficos de suma acumulativa simple y de suma acumulativa de Bernoulli de dos caras. RESULTADOS: Fueron incluidos 54 procedimientos. En el análisis se presentan una curva de aprendizaje de un solo cirujano (n = 35) y una curva de aprendizaje institucional. En la curva de aprendizaje de un solo cirujano, se detectó un punto de inflexión que marcaba el final de una fase de aprendizaje en el duodécimo procedimiento para el número de ganglios extraídos y en el vigésimo para la retención urinaria. En el análisis de la curva de aprendizaje institucional, se identificaron dos puntos de inflexión en las intervenciones 13.ª y 26.ª, que indicaron mejoras progresivas en el número de ganglios extraídos, y en la 27.ª en la retención urinaria. No se detectaron señales de alarma sostenidas en ningún momento. LIMITACIONES: La naturaleza retrospectiva, el pequeño tamaño de la muestra y la naturaleza de centro de referencia de la institución informante que pueden limitar la capacidad de generalizarse. CONCLUSIONES: En un entorno de experiencia institucional con cirugía robótica colorrectal incluyendo más allá de las resecciones TME, la curva de aprendizaje para la disección robótica de ganglios linfáticos pélvicos laterales es aceptablemente corta. Nuestros resultados demuestran la viabilidad de la adquisición de esta técnica en un entorno controlado, con un volumen de casos suficiente y una supervisión que puede optimizar la curva de aprendizaje. (Traducción—Dr. Osvaldo Gauto)
- Open Access
- 8 May 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (8) , 985-986
Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything
Dear Editor
- 8 May 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (8) , 985-986
Open AccessTherapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything
Dear Editor